Skip to main navigation Skip to search Skip to main content

Cost effectiveness and cost utility of acetylcysteine versus dimethyl sulfoxide for reflex sympathetic dystrophy

  • HEM van Dieten
  • , R.S.G.M. Perez
  • , MW van Tulder
  • , JJ de Lange
  • , W.W.A. Zuurmond
  • , H.J. Ader
  • , H. Vondeling
  • , M Boers

Research output: Contribution to JournalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)139-148
JournalPharmaco Economics
Volume21
Issue number2
DOIs
Publication statusPublished - 2003

Cite this